Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

Pietro Ciceri(DiscoveRx (United States)), Susanne Müller(Nuffield Orthopaedic Centre), Alison O’Mahony(DiscoveRx (United States)), O. Fedorov(University of Oxford), P. Filippakopoulos(University of Oxford), Jeremy P. Hunt(DiscoveRx (United States)), Elisabeth A. Lasater(University of California, San Francisco), Gabriel Pallares(DiscoveRx (United States)), S. Picaud(University of Oxford), Christopher Wells(Nuffield Orthopaedic Centre), Sarah Martin(University of Oxford), Lisa Wodicka(DiscoveRx (United States)), Neil P. Shah(University of California, San Francisco), Daniel K. Treiber(DiscoveRx (United States)), Stefan Knapp(Nuffield Orthopaedic Centre)
Nature Chemical Biology
March 2, 2014
10.1038/nchembio.1471
Cited by 349Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis